All News

At this year's Annual ASH Meeting & Exposition, eight people were recognized as MPN Heroes, and, new this year, a ninth individual was honored as the program’s first Canadian MPN Champion - all for their commitment to the individual and commitment to the broader MPN community.

The Mattie Miracle Cancer Foundation is dedicated to addressing the psychological needs of children and families with childhood cancer. It also aims to educate health care providers about potential psychosocial effects of a diagnosis.

Two-time cancer survivor offers ways to reduce clutter during the holidays and beyond.

A supplemental new drug application (sNDA) for Rubraca (rucaparib), a PARP inhibitor, has been granted a priority review by the Food and Drug Administration.

Key takeaways from the National Comprehensive Cancer Network® (NCCN)’s Patient Advocacy Summit reveal progress made toward improving survivorship care and planning, and identify opportunities for improvement.

The FDA has granted Avastin (bevacizumab) a full approval for the treatment of adult patients with glioblastoma who progressed following prior therapy, according to Genentech, the manufacturer of the VEGF inhibitor.

Patient Advocacy Summit brings together advocacy organizations and other key stakeholders to share ideas about how to improve survivors’ quality of life.

A study finds that patients often turn to the internet for information regarding their cancer diagnosis, but more often than not, they still rely on healthcare providers in their decision-making process.

Longer time in between pre- and postoperative chemotherapy may be associated with significantly worse survival outcomes in women with ovarian cancer.

At the National Comprehensive Cancer Network® (NCCN)’s Patient Advocacy Summit – a meeting designed to share best practices for survivorship planning care among advocacy organizations – Yelak Biru shared his story of survivorship, and how he has been able to integrate multiple myeloma into his life for more than two decades.

Learning to accept the physical changes breast cancer creates is often difficult, but doable. It takes time to learn to embrace change but doing so is beneficial to well being.

During cancer treatment, patients lose a lot of things, but one thing that’s constantly noticed is hair loss.

Treatment options for patients with HER2-positive breast cancer continue to expand, especially after the Food and Drug Administration (FDA) approval of Nerlynx (neratinib) earlier in 2017 and the more recent priority review designation of Perjeta (pertuzumab).

After tracking the progress of about 20 patients with brain cancer who used cannabis, a neuro-oncologist found that the substance caused them no harm, had few side effects and did not interfere with conventional treatments.

To offset an increased risk for serious side effects, patients with chronic lymphocytic leukemia say they prefer a substantial increase in progression-free survival in order to accept this negative treatment attribute.

A researcher discusses the exciting times surrounding the development of novel agents designed to treat multiple myeloma.

Imagine being diagnosed at the age of 21 as a never-smoking individual and college athlete.

Breast cancer survivor shares her journey after testing positive for a newly discovered genetic mutation (PALB2) related to breast cancer.

Treatment for metastatic cancer can mean asking a tough question every single day.

Taking time to show gratitude for compassionate care is important. It can be done any time of year but the holiday season offers a perfect opportunity.

Cancer treatment isn't what it used to be, and it is important that patients and their loved ones understand that.

This cancer survivor learned how mindfulness can change the way we heal.

Do a few weeks delay in surgery really impact outcomes for patients with colon cancer?

As PARP inhibitors continue to improve outcomes in patients with ovarian cancer, they may one day be moved into the frontline treatment setting, said Susana M. Campos, M.D., a gynecologic oncologist at Dana-Farber Cancer Institute and an assistant professor at Harvard Medical School.

There are plenty of things to talk about that can keep your mind from the fears and concerns that hover around cancer.

Lymphedema is a common side effect that may affect a cancer survivor months or even years after treatments such as surgery or radiation therapy. Here are some tips to help manage lymphedema.

Cancer survivor and motivational clutter-clearing trainer offers ideas to clear the clutter and the stress from your holidays.